Quantifying changes in local basal ganglia structural connectivity in the 6-hydroxydopamine model of Parkinson's Disease using correlational tractography

被引:0
|
作者
Moshchin, Mikhail [1 ]
Cheng, Kevin P. [1 ]
Osting, Susan [1 ]
Laluzerne, Matthew [1 ]
Hurley, Samuel A. [1 ]
Singh, Ajay Paul [1 ]
Trevathan, James K. [1 ]
Brzeczkowski, Andrea [1 ]
Yu, John-Paul J. [1 ]
Lake, Wendell B. [1 ]
Ludwig, Kip A. [1 ]
Suminski, Aaron J. [1 ]
机构
[1] Univ Wisconsin Madison, Madison, WI 53706 USA
关键词
Parkinson's disease; 6-OHDA; ex-vivo magnetic resonance imaging; diffusion tensor imaging; quantitative anisotropy; deterministic tractography; DEGENERATION; DOPAMINE;
D O I
10.1109/NER52421.2023.10123839
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
In recent years, tractography based on diffusion magnetic resonance imaging (dMRI) has become a popular tool for studying microstructural changes resulting from brain diseases like Parkinson's Disease (PD). Quantitative anisotropy (QA) is a parameter that is used in deterministic fiber tracking as a measure of connection between brain regions. It remains unclear, however, if microstructural changes caused by lesioning the median forebrain bundle (MFB) to create a Parkinsonian rat model can be resolved using tractography based on ex-vivo diffusion MRI. This study aims to fill this gap and enable future mechanistic research on structural changes of the whole brain network rodent models of PD. Specifically, it evaluated the ability of correlational tractography to detect structural changes in the MFB of 6-hydroxydopamine (6-OHDA) lesioned rats. The findings reveal that correlational tractography can detect structural changes in lesioned MFB and differentiate between the 6-OHDA and control groups. Imaging results are supported by behavioral and histological evidence demonstrating that 6-OHDA lesioned rats were indeed Parkinsonian. The results suggest that QA and correlational tractography is appropriate to examine local structural changes in rodent models of neurodegenerative disease. More broadly, we expect that similar techniques may provide insight on how disease alters structure throughout the brain, and as a tool to optimize therapeutic interventions.
引用
收藏
页数:4
相关论文
共 50 条
  • [41] Metabolic-dopaminergic mapping of the 6-hydroxydopamine rat model for Parkinson's disease
    Casteels, Cindy
    Lauwers, Erwin
    Bormans, Guy
    Baekelandt, Veerle
    Van Laere, Koen
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (01) : 124 - 134
  • [42] Upregulation of Cysteine Protease Cathepsin X in the 6-Hydroxydopamine Model of Parkinson's Disease
    Pislar, Anja
    Tratnjek, Larisa
    Glavan, Gordana
    Zivin, Marko
    Kos, Janko
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2018, 11
  • [43] Behavioral and morphological effects of minocycline in the 6-hydroxydopamine rat model of Parkinson's disease
    Quintero, Elias Matthew
    Willis, Lauren
    Singleton, Rachel
    Harris, Naida
    Huang, Peng
    Bhat, Narayan
    Granholm, Ann-Charlotte
    BRAIN RESEARCH, 2006, 1093 : 198 - 207
  • [44] Effects of puerarin on gait disturbance in a 6-hydroxydopamine mouse model of Parkinson's disease
    Kim, Na-Hyun
    Goto, Yukiori
    Lee, Young-A
    PHARMACOLOGICAL REPORTS, 2025, 77 (01) : 247 - 259
  • [45] Neuroprotective effect of bromelain in 6-hydroxydopamine induced in vitro model of Parkinson's disease
    Okkay, Irmak Ferah
    Okkay, Ufuk
    Cicek, Betul
    Yilmaz, Aysegul
    Yesilyurt, Fatma
    Mendil, Ali Sefa
    Hacimuftuoglu, Ahmet
    MOLECULAR BIOLOGY REPORTS, 2021, 48 (12) : 7711 - 7717
  • [46] Paeonol Protection Against Intrastriatal 6-Hydroxydopamine Rat Model of Parkinson's Disease
    Ghalami, Jamileh
    Mojarad, Tourandokht Baluchnejad
    Mansouri, Monireh
    Khamse, Safoura
    Roghani, Mehrdad
    BASIC AND CLINICAL NEUROSCIENCE, 2021, 12 (01) : 43 - 55
  • [47] The footfault test as a screening tool in the 6-hydroxydopamine rat model of Parkinson's disease
    Silvestrin, Roberta Bristot
    de Oliveira, Lucas Fuerstenau
    Batassini, Cristiane
    Oliveira, Alcyr
    Mello e Souza, Tadeu
    JOURNAL OF NEUROSCIENCE METHODS, 2009, 177 (02) : 317 - 321
  • [48] Use of the narrow beam test in the rat, 6-hydroxydopamine model of Parkinson's disease
    Allbutt, Haydn N.
    Henderson, Jasmine M.
    JOURNAL OF NEUROSCIENCE METHODS, 2007, 159 (02) : 195 - 202
  • [49] Behavioural effects of basal ganglia rho-kinase inhibition in the unilateral 6-hydroxydopamine rat model of Parkinson's disease (vol 31, pg 849, 2016)
    Inan, Salim Yalcin
    Soner, Burak Cem
    Sahin, Ayse Saide
    METABOLIC BRAIN DISEASE, 2016, 31 (04) : 859 - 859
  • [50] 6-hydroxydopamine lesions in anuran amphibians: A new model system for Parkinson's disease?
    Endepols, H
    Schul, J
    Gerhardt, HC
    Walkowiak, W
    JOURNAL OF NEUROBIOLOGY, 2004, 60 (04): : 395 - 410